Article: Chiron: No Begrivac Due For Overseas This Season.

West Coast Editor

Like a persistent bug, Chiron Corp.'s problems related to the influenza vaccine remain with the company, although Wall Street seems to be taking the latest unfavorable news in stride.

Chiron said no Begrivac flu vaccine, which the company has been making for the German and UK markets, will be available this year. Earlier, Chiron had said production for the 2005-2006 flu season would drop from about 12 million doses to about 4 million because of manufacturing problems. (See BioWorld Today, July 18, 2005.)

The company's stock (NASDAQ:CHIR) closed Wednesday at $35.89, unchanged, though analyst Jennifer Chao of Deutsche Bank wrote ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!